LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma

被引:42
作者
Kong, Cheng [1 ,2 ]
Zhu, Xiang-zhi [1 ,2 ]
Lee, Tsair-Fwu [3 ,4 ]
Feng, Ping-bo [1 ,2 ]
Xu, Jian-hua [1 ,2 ]
Qian, Pu-dong [1 ,2 ]
Zhang, Lan-fang [2 ,5 ]
He, Xia [1 ,2 ]
Huang, Sheng-fu [1 ,2 ]
Zhang, Yi-qin [1 ,2 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China
[2] Canc Ctr Jiangsu Prov, Nanjing, Jiangsu, Peoples R China
[3] Natl Kaohsiung Univ Appl Sci, Med Phys & Informat Lab Elect Engn, Kaohsiung 80778, Taiwan
[4] Kaohsiung Med Univ, Inst Clin Med, Kaohsiung 807, Taiwan
[5] Nanjing Med Univ, Affiliated Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
DOSIMETRIC FACTORS; LATE TOXICITIES; THERAPY; RISK; NECROSIS; PATIENT; VOLUME; CHEMOTHERAPY; XEROSTOMIA;
D O I
10.1038/srep26378
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We investigated the incidence of temporal lobe injury (TLI) in 132 nasopharyngeal carcinoma (NPC) patients who had undergone intensity-modulated radiotherapy (IMRT) in our hospital between March 2005 and November 2009; and identified significant dosimetric predictors of TLI development. Contrast-enhanced lesions or cysts in the temporal lobes, as detected by magnetic resonance imaging (MRI), were regarded as radiation-induced TLIs. We used the least absolute shrinkage and selection operator (LASSO) method to select D-max (the maximum point dose) and the D-1cc (the top dose delivered to a 1-mL volume) from 15 dose-volume-histogram-associated and four clinically relevant candidate factors; the D-max and the D-1cc were the most significant predictors of TLI development. We drew dose-response curves for D-max and D-1cc. The tolerance dose (TD) for the 5% and 50% probabilities of TLI development were 69.0 +/- 1.6 and 82.1 +/- 2.4 Gy for D-max and 62.8 +/- 2.2 and 80.9 +/- 3.4 Gy for D-1cc, respectively. The incidence of TLI in NPC patients after IMRT was higher than expected because the therapeutic window is narrow. High-quality longitudinal studies are needed to gain further insight into the complex spatiotemporal effects of non-uniform irradiation on TLI development in NPC patients.
引用
收藏
页数:8
相关论文
共 23 条
[1]   HYPOFRACTIONATED DOSE-PAINTING INTENSITY MODULATED RADIATION THERAPY WITH CHEMOTHERAPY FOR NASOPHARYNGEAL CARCINOMA: A PROSPECTIVE TRIAL [J].
Bakst, Richard L. ;
Lee, Nancy ;
Pfister, David G. ;
Zelefsky, Michael J. ;
Hunt, Margie A. ;
Kraus, Dennis H. ;
Wolden, Suzanne L. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (01) :148-153
[2]   Temporal Changes in IMRT Contouring of Organs at Risk for Nasopharyngeal Carcinoma - The Learning Curve Blues and a Tool that Could Help [J].
Baxi, Siddhartha ;
Park, Eileen ;
Chong, Vincent ;
Chung, Hans T. .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2009, 8 (02) :131-140
[3]  
Bentzen S. M., 2009, BASIC CLIN RADIOBIOL, V57
[4]   Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma [J].
Cheung, MC ;
Chan, AS ;
Law, SC ;
Chan, JH ;
Tse, VK .
CANCER, 2003, 97 (08) :2019-2026
[5]  
Edge SB., 2010, AJCC Cancer Staging Manual, V7th, P41
[6]   RADIATION DOSE-VOLUME EFFECTS IN THE BRAIN [J].
Lawrence, Yaacov Richard ;
Li, X. Allen ;
el Naqa, Issam ;
Hahn, Carol A. ;
Marks, Lawrence B. ;
Merchant, Thomas E. ;
Dicker, Adam P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03) :S20-S27
[7]   MAJOR LATE TOXICITIES AFTER CONFORMAL RADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA-PATIENT- AND TREATMENT-RELATED RISK FACTORS [J].
Lee, Anne W. M. ;
Ng, W. T. ;
Hung, W. M. ;
Choi, C. W. ;
Tung, Raymond ;
Ling, Y. H. ;
Cheng, Peter T. C. ;
Yau, T. K. ;
Chang, Amy T. Y. ;
Leung, Samuel K. C. ;
Lee, Michael C. H. ;
Bentzen, Soren M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04) :1121-1128
[8]   Factors affecting risk of symptomatic temporal lobe necrosis: Significance of fractional dose and treatment time [J].
Lee, AWM ;
Kwong, DLW ;
Leung, SF ;
Tung, SY ;
Sze, WM ;
Sham, JST ;
Teo, PML ;
Leung, TW ;
Wu, PM ;
Chappell, R ;
Peters, LJ ;
Fowler, JF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01) :75-85
[9]   Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225 [J].
Lee, Nancy ;
Harris, Jonathan ;
Garden, Adam S. ;
Straube, William ;
Glisson, Bonnie ;
Xia, Ping ;
Bosch, Walter ;
Morrison, William H. ;
Quivey, Jeanne ;
Thorstad, Wade ;
Jones, Christopher ;
Ang, K. Kian .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) :3684-3690
[10]   Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy [J].
Lee, Tsair-Fwu ;
Liou, Ming-Hsiang ;
Ting, Hui-Min ;
Chang, Liyun ;
Lee, Hsiao-Yi ;
Leung, Stephen Wan ;
Huang, Chih-Jen ;
Chao, Pei-Ju .
SCIENTIFIC REPORTS, 2015, 5